A post-authorisation, non-interventional, retrospective, drug-utilisation study to describe the pattern of use of lenalidomide in patients with myelodysplastic syndromes (MDS) (CC-5013-MDS-012) First published 12/03/2018 Last updated 05/02/2025 EU PAS number:EUPAS22604 Study Finalised